Spruce Biosciences (SPRB) Return on Assets (2020 - 2026)
Spruce Biosciences (SPRB) posted quarterly Return on Assets of 0.01% for Q1 2026, up 1.0% year-over-year from 0.01% in Q1 2025, and up 24.34% quarter-over-quarter from 0.01% in Q4 2025.
Spruce Biosciences (SPRB) Return on Assets (2020 - 2026) Analysis & Trends
Spruce Biosciences (SPRB) has reported Return on Assets for 7 consecutive years, with 0.01% the latest figure, recorded in Q1 2026.
- In Q1 2026, Return on Assets rose 1.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
- Return on Assets advanced to 0.01% in Q1 2026 per SPRB's latest filing, from 0.01% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q2 2023 and bottomed at 0.03% in Q3 2025.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2024.
- Annual changes were most pronounced in 2025 — Return on Assets declined 2 bps — and 2026, when it rose 1 bps.
- Spruce Biosciences' Return on Assets stood at 0.01% in 2022, then rose by 8 bps to 0.0% in 2023, then plunged by 100 bps to 0.01% in 2024, then slipped by 9 bps to 0.01% in 2025, then increased by 24 bps to 0.01% in 2026.
- Business Quant data shows SPRB's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.03% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 0.00% |
| 10 | Spruce Biosciences | 122.59 Mn | 122.59 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.01% |
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | -0.01% |
| Sep 30, 2025 | -0.03% |
| Jun 30, 2025 | -0.02% |
| Mar 31, 2025 | -0.01% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | 0.00% |